|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2005-8-9
|
|
pubmed:abstractText |
Many veterans may not be candidates for hepatitis C virus (HCV) treatment due to contraindications to therapy. The aims of this study were to determine the proportion of HCV-infected veterans who were eligible for interferon alfa and ribavirin therapy and to evaluate barriers to HCV treatment.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
pubmed-author:AhmadJawadJ,
pubmed-author:AnandBhupinderjit SBS,
pubmed-author:AwadJosephJ,
pubmed-author:AytamanAyseA,
pubmed-author:BiniEdmund JEJ,
pubmed-author:BräuNorbertN,
pubmed-author:ChangKyong-MiKM,
pubmed-author:CheungRamseyR,
pubmed-author:CurrieSueS,
pubmed-author:HagedornCurtC,
pubmed-author:HoSamuel BSB,
pubmed-author:HuKe-QinKQ,
pubmed-author:JeffersLennoxL,
pubmed-author:JohnsonDavidD,
pubmed-author:KingPaulP,
pubmed-author:MendenhallCharlesC,
pubmed-author:MorganTimothy RTR,
pubmed-author:MoseleyRichardR,
pubmed-author:PedrosaMarcosM,
pubmed-author:RossiStephenS,
pubmed-author:SasakiAnna WAW,
pubmed-author:SchmidtWarren NWN,
pubmed-author:ShenHuiH,
pubmed-author:SimonFranzF,
pubmed-author:StraderDorisD,
pubmed-author:WatersBradfordB,
pubmed-author:WrightTeresa LTL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
100
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1772-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16086714-Antiviral Agents,
pubmed-meshheading:16086714-Female,
pubmed-meshheading:16086714-Hepatitis C, Chronic,
pubmed-meshheading:16086714-Humans,
pubmed-meshheading:16086714-Interferon-alpha,
pubmed-meshheading:16086714-Male,
pubmed-meshheading:16086714-Mental Disorders,
pubmed-meshheading:16086714-Middle Aged,
pubmed-meshheading:16086714-Patient Acceptance of Health Care,
pubmed-meshheading:16086714-Patient Selection,
pubmed-meshheading:16086714-Ribavirin,
pubmed-meshheading:16086714-Substance-Related Disorders,
pubmed-meshheading:16086714-Treatment Outcome,
pubmed-meshheading:16086714-United States,
pubmed-meshheading:16086714-Veterans
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
|
|
pubmed:affiliation |
VA New York Harbor Healthcare System and NYU School of Medicine, New York, New York 10010, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
